APOGEE THERAPEUTICS INC (APGE)
NASDAQ • Healthcare
$134.57
-$0.02 (-0.0%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About APOGEE THERAPEUTICS INC
Name
APOGEE THERAPEUTICS INC
CEO
Michael Thomas Henderson
Website
Industry
Healthcare
Year Founded
2022
Employees
261
Apogee Therapeutics, Inc. is a NASDAQ-listed biotechnology company in the healthcare sector that develops antibody medicines for inflammatory and immunological diseases. In qualitative terms, it is an early-stage biotech built around a small pipeline of subcutaneous biologics, with programs led by APG777 for atopic dermatitis and APG808 for chronic obstructive pulmonary disease.
Fundamentals & Financials
Revenue (TTM)
$0
Net Income (TTM)
-$294.3M
EPS (TTM)
-$4.34
ROA (TTM)
-22.04%
Current Ratio
26.44
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$134.57$134.54 - $134.6
52 Week RangeAvg. Volume$35.39 - $134.881.1M
Market Cap$8.3B
Peers & Related Assets
CGONCG ONCOLOGY INC
$76.29-1.1%
XENEXENON PHARMACEUTICALS INC
$63.18+1.3%
CELCCELCUITY INC
$93.24+0.9%
IRONDISC MEDICINE INC
$80.2+0.2%
RAREULTRAGENYX PHARMACEUTICAL INC
$25.49-2.5%
CNTACentessa Pharmaceuticals plc
LEGNLegend Biotech Corporation
ZLABZai Lab Limited
AAPGAscentage Pharma Group International
SLNOSOLENO THERAPEUTICS INC